These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 3449990

  • 1. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected].
    Desjeux P, Mollinedo S, Le Pont F, Paredes A, Ugarte G.
    Trans R Soc Trop Med Hyg; 1987; 81(5):742-6. PubMed ID: 3449990
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous leishmaniasis in French Guiana: a review.
    Dedet JP.
    Am J Trop Med Hyg; 1990 Jul; 43(1):25-8. PubMed ID: 2200289
    [Abstract] [Full Text] [Related]

  • 3. In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis.
    Baptista C, Miranda Lde F, Madeira Mde F, Leon LL, Conceição-Silva F, Schubach Ade O.
    Dis Markers; 2015 Jul; 2015():943236. PubMed ID: 25802480
    [Abstract] [Full Text] [Related]

  • 4. Leishmaniasis in Bolivia. II. The involvement of Psychodopygus yucumensis and Psychodopygus llanosmartinsi in the selvatic transmission cycle of Leishmania braziliensis braziliensis in a lowland subandean region.
    Le Pont F, Desjeux P.
    Mem Inst Oswaldo Cruz; 1986 Jul; 81(3):311-8. PubMed ID: 3574129
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
    Romero GA, Guerra MV, Paes MG, Macêdo VO.
    Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
    [Abstract] [Full Text] [Related]

  • 6. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
    Perez-Franco JE, Cruz-Barrera ML, Robayo ML, Lopez MC, Daza CD, Bedoya A, Mariño ML, Saavedra CH, Echeverry MC.
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.
    Netto EM, Marsden PD, Llanos-Cuentas EA, Costa JM, Cuba CC, Barreto AC, Badaró R, Johnson WD, Jones TC.
    Trans R Soc Trop Med Hyg; 1990 May; 84(3):367-70. PubMed ID: 2260171
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
    Gagini T, de Oliveira Schubach A, de Fatima Madeira M, Maria Valete-Rosalino C, Fernandes Pimentel MI, da Silva Pacheco R.
    Parasite; 2017 May; 24():34. PubMed ID: 28959938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB, Mendonça SC, Callahan H, Portal AC, Max G.
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.
    Sinagra A, Luna C, Abraham D, Iannella Mdel C, Riarte A, Krolewiecki AJ.
    Rev Soc Bras Med Trop; 2007 Jun; 40(6):627-30. PubMed ID: 18200413
    [Abstract] [Full Text] [Related]

  • 15. [American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis in military training area of Zona da Mata in Pernambuco].
    Andrade MS, Brito ME, Silva ST, Lima BS, Almeida EL, Albuquerque EL, Marinho Júnior JF, Ishikawa E, Cupolillo E, Brandão-Filho SP.
    Rev Soc Bras Med Trop; 2005 Jun; 38(3):229-33. PubMed ID: 15895173
    [Abstract] [Full Text] [Related]

  • 16. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM, Marsden PD.
    Rev Soc Bras Med Trop; 1988 Jun; 21(2):85-6. PubMed ID: 3249826
    [No Abstract] [Full Text] [Related]

  • 17. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A, Porrozzi R, Oliveira-Neto MP, Grimaldi GJ.
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [Abstract] [Full Text] [Related]

  • 18. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
    Membrive NA, Kazuma FJ, Silveira TGV, Teixeira JJV, Reinhold-Castro KR, Teodoro U.
    Rev Inst Med Trop Sao Paulo; 2017 Jun 01; 59():e37. PubMed ID: 28591265
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
    Machado ES, Braga Mda P, Da Cruz AM, Coutinho SG, Vieira AR, Rutowitsch MS, Cuzzi-Maya T, Grimaldi júnior G, Menezes JA.
    Mem Inst Oswaldo Cruz; 1992 Jun 01; 87(4):487-92. PubMed ID: 1343662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.